EIF2AK3 and major depressive disorder: These findings establish astrocytic PERK deficiency as a sufficient driver of synaptic and network dysfunction underlying depressive phenotypes and highlight astrocyte-directed TSP1 augmentation as a potential therapeutic strategy for MDD.